The podocyte's response to injury: Role in proteinuria and glomerulosclerosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Shankland, 1999, Cell cycle regulatory proteins in glomerular disease, Exp Nephrol, 7, 207, 10.1159/000020603
Saxen, 1997
Mundel, 1995, Structure and function of podocytes: an update [Review article], Anat Embryol, 192, 385, 10.1007/BF00240371
Adler, 1992, Anti-Fx1A antibody recognizes a beta-1-integrin on glomerular epithelial cells and inhibits adhesion and growth, Am J Physiol, 262, F770
Kojima, 2002, Is podocyte shape controlled by the dystroglycan complex?, Nephrol Dial Transplant, 17, 23, 10.1093/ndt/17.suppl_9.23
Mundel, 1997, Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines, Exp Cell Res, 236, 248, 10.1006/excr.1997.3739
Mundel, 1997, Synaptodopodin: an actin-associated protein in telencephalic dendrites and renal podocytes, J Cell Biol, 139, 193, 10.1083/jcb.139.1.193
Kaplan, 2000, Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis, Nat Genet, 24, 251, 10.1038/73456
Kerjaschki, 2001, Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis, J Clin Invest, 108, 1583, 10.1172/JCI200114629
Ruotsalainen, 1999, Nephrin is specifically located at the slit diaphragm of glomerular podocytes, Proc Natl Acad Sci USA, 96, 7962, 10.1073/pnas.96.14.7962
Roselli, 2002, Podocin localizes in the kidney to the slit diphragm area, Am J Pathol, 160, 131, 10.1016/S0002-9440(10)64357-X
Huber, 2001, Interaction with podocin facilitates nehrin signaling, J Biol Chem, 276, 4153, 10.1074/jbc.C100452200
Schwarz, 2001, Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin, J Clin Invest, 108, 1621, 10.1172/JCI200112849
Shih, 2001, CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain, Am J Pathol, 159, 2303, 10.1016/S0002-9440(10)63080-5
Li, 2000, CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere, Am J Physiol Renal Physiol, 279, F785, 10.1152/ajprenal.2000.279.4.F785
Sellin, 2003, NEPH1 defines a novel family of podocin interacting proteins, FASEB J, 17, 115, 10.1096/fj.02-0242fje
Benzing, 2004, Signaling at the slit diaphragm, J Am Soc Nephrol, 15, 1382, 10.1097/01.ASN.0000130167.30769.55
Ahola, 2003, A novel protein, densin, expressed by glomerular podocytes, J Am Soc Nephrol, 14, 1731, 10.1097/01.ASN.0000075553.33781.9F
Kerjaschki, 1984, Identification and characterization of podocalyxin – the major sialoprotein of the renal glomerular epithelial cell, J Cell Biol, 98, 1591, 10.1083/jcb.98.4.1591
Matsui, 1999, Podoplanin, a novel 43-kDa membrane protein, controls the shape of podocytes, Nephrol Dial Transplant, 14, 9, 10.1093/ndt/14.suppl_1.9
Kriedberg, 1996, Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis, Development, 122, 3537, 10.1242/dev.122.11.3537
Raats, 2000, Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies, Am J pathol, 156, 1749, 10.1016/S0002-9440(10)65046-8
Tryggvason, 1999, Discovery of the congenital nephrotic syndrome gene discloses the structure of the mysterious molecular sieve of the kidney, Int J Dev Biol, 43, 445
Kestila, 1998, Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome, Mol Cell, 1, 575, 10.1016/S1097-2765(00)80057-X
Ronco, 2005, Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization, J Am Soc Nephrol, 16, 1205, 10.1681/ASN.2004121080
Debiec, 2004, Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies, Lancet, 364, 1252, 10.1016/S0140-6736(04)17142-0
Kim, 2003, CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility, Science, 300, 1298, 10.1126/science.1081068
Boute, 2000, NPHS2 encoding the glomerular proteins podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome, Nat Genet, 24, 349, 10.1038/74166
Winn, 2005, A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis, Science, 308, 1801, 10.1126/science.1106215
Reiser, 2005, TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function, Nat Genet, 37, 739, 10.1038/ng1592
Kerjaschki, 1996, Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis), J Am Soc Nephrol, 7, 2518, 10.1681/ASN.V7122518
Ross, 2002, Recent progress in HIV-associated nephropathy, J Am Soc Nephrol, 13, 2997, 10.1097/01.ASN.0000040750.40907.99
Pagtalunan, 1997, Podocyte loss and progressive glomerular injury in type II diabetes, J Clin Invest, 99, 342, 10.1172/JCI119163
Durvasula, 2004, Activation of a local tissue angiotensin system in podocytes by mechanical strain, Kidney Int, 65, 30, 10.1111/j.1523-1755.2004.00362.x
Endlich, 2001, Podocytes respond to mechanical stress in vitro, J Am Soc Nephrol, 12, 413, 10.1681/ASN.V123413
Tsukaguchi, 2002, NPHS2 mutations in late-onset focal segmental glomerulosclerosis. R229Q is a common disease-associated allele, J Clin Invest, 110, 1659, 10.1172/JCI0216242
Farquhar, 1957, An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus, J Exp Med, 106, 649, 10.1084/jem.106.5.649
Drumond, 1994, Structural basis for reduced glomerular filtration capacity in nephrotic humans, J Clin Invest, 94, 1187, 10.1172/JCI117435
Inokuchi, 1996, Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis, Kidney Int, 50, 1278, 10.1038/ki.1996.439
Shirato, 2002, Podocyte process effacement in vivo, Microsc Res Technol, 57, 241, 10.1002/jemt.10082
Liu, 2003, Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability, J Clin Invest, 112, 209, 10.1172/JCI200318242
Topham, 1999, Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin, J Clin Invest, 104, 1559, 10.1172/JCI7728
Seefeldt, 1981, Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis, Lab Invest, 44, 541
Lahdenkari, 2004, Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria, J Am Soc Nephrol, 15, 2611, 10.1097/01.ASN.0000139478.03463.D9
Patrakka, 2002, The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome, Pediatr Res, 52, 349, 10.1203/00006450-200209000-00007
van den Berg, 2004, Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies, Kidney Int, 66, 1901, 10.1111/j.1523-1755.2004.00964.x
Mundel, 1999, Glomerular podocytes and adhesive interaction with glomerular basement membrane, Exp Nephrol, 7, 160, 10.1159/000020596
Ichimura, 2003, Actin filament organization of foot processes in rat podocytes, J Histochem Cytochem, 51, 1589, 10.1177/002215540305101203
Smoyer, 1997, Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome, Am J Physiol, 273, F150
Kos, 2003, Mice deficient in alpha-actinin-4 have severe glomerular disease, J Clin Invest, 111, 1683, 10.1172/JCI17988
Michaud, 2003, Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4, J Am Soc Nephrol, 14, 1200, 10.1097/01.ASN.0000059864.88610.5E
Asanuma, 2005, Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner, J Clin Invest, 115, 1188, 10.1172/JCI200523371
Tryggvason, 1999, Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm, J Am Soc Nephrol, 10, 2440, 10.1681/ASN.V10112440
Donoviel, 2001, Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to Nephrin, Mol Cell Biol, 21, 4829, 10.1128/MCB.21.14.4829-4836.2001
Inoue, 2001, FAT is a component of glomerular slit diaphragms, Kidney Int, 59, 1003, 10.1046/j.1523-1755.2001.0590031003.x
Yuan, 2002, Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nehropathy, J Am Soc Nephrol, 13, 946, 10.1681/ASN.V134946
Kretzler, 2002, Regulation of adhesive interaction between podocytes and glomerular basement membrane, Microsc Res Technol, 57, 247, 10.1002/jemt.10083
Kojima, 2004, Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan–matrix interaction, J Am Soc Nephrol, 15, 2079, 10.1097/01.ASN.0000133531.43177.21
Cybulsky, 1992, Adhesion of rat glomerular epithelial cells to extracellular matrices: role of β1 integrins, Kidney Int, 42, 1099, 10.1038/ki.1992.393
Kretzler, 2001, Integrin linked kinase as a candidate downstream effector in proteinuria, FASEB J, 15, 1843, 10.1096/fj.00-0832fje
Griffin, 2004, Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology, Am J Pathol, 165, 1175, 10.1016/S0002-9440(10)63378-0
Kurihara, 1992, The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1, Am J Pathol, 141, 805
Economou, 2004, Enhanced podocalyxin expression alters the structure of podocyte basal surface, J Cell Sci, 117, 3281, 10.1242/jcs.01163
Schmieder, 2004, Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells, J Am Soc Nephrol, 15, 2289, 10.1097/01.ASN.0000135968.49899.E8
Matsui, 1998, Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes [In Process Citation], J Am Soc Nephrol, 9, 2013, 10.1681/ASN.V9112013
Kriz, 1998, Progression of glomerular diseases: is the podocyte the culprit?, Kidney Int, 54, 687, 10.1046/j.1523-1755.1998.00044.x
Lemley, 2002, Podocytopenia and disease severity in IgA nephropathy, Kidney Int, 61, 1475, 10.1046/j.1523-1755.2002.00269.x
Steffes, 2001, Glomerular cell number in normal subjects and type I diabetic patients, Kidney Int, 59, 2104, 10.1046/j.1523-1755.2001.00725.x
White, 2004, Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients, Nephrol Dial Transplant, 19, 1437, 10.1093/ndt/gfh129
Kriz, 1998, From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies, Nephrol Dial Transplant, 13, 2781, 10.1093/ndt/13.11.2781
Kriz, 1994, The role of podocytes in the development of glomerular sclerosis, Kidney Int, 45, S64
Hara, 2005, Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury, J Am Soc Nephrol, 16, 408, 10.1681/ASN.2004070564
Hara, 2001, Urinary podocytes in primary focal segmental glomerulosclerosis, Nephron, 89, 342, 10.1159/000046097
Hara, 1997, Immunohistochemical and urinary markers of podocyte injury, Pediatr Nephrol, 12, 43, 10.1007/s004670050401
Nakamura, 2001, Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria, Metabolism, 50, 1193, 10.1053/meta.2001.26703
Nakamura, 2000, Urinary excretion of podocytes in patients with diabetic nephropathy, Nephrol Dial Transplant, 15, 1379, 10.1093/ndt/15.9.1379
Nakamura, 2000, Urinary podocytes for the assessment of disease activity in lupus nephritis, Am J Med Sci, 320, 112, 10.1097/00000441-200008000-00009
Vogelmann, 2003, Urinary excretion of viable podocytes in health and renal disease, Am J Physiol Renal Physiol, 285, F40, 10.1152/ajprenal.00404.2002
Petermann, 2003, Podocytes that detach in experimental membranous nephropathy are viable, Kidney Int, 64, 1222, 10.1046/j.1523-1755.2003.00217.x
Petermann, 2004, Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis, Nephron Exp Nephrol, 98, e114, 10.1159/000081555
Yu, 2005, Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria, J Am Soc Nephrol, 16, 1733, 10.1681/ASN.2005020159
Chen, 2000, Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes, Life Sci, 67, 2345, 10.1016/S0024-3205(00)00815-8
Schiffer, 2001, Apoptosis in podocytes induced by TGF-beta and Smad7, J Clin Invest, 108, 807, 10.1172/JCI200112367
Kim, 2001, Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat, Kidney Int, 60, 957, 10.1046/j.1523-1755.2001.060003957.x
Ding, 2002, Angiotensin II induces apoptosis in rat glomerular epithelial cells, Am J Renal Physiol, 283, F173, 10.1152/ajprenal.00240.2001
Huber, 2003, Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling, Mol Cell Biol, 23, 4917, 10.1128/MCB.23.14.4917-4928.2003
Foster, 2003, Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes, Am J Physiol Renal Physiol, 284, F1263, 10.1152/ajprenal.00276.2002
Wada, 2005, The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis, Kidney Int, 68, 1618, 10.1111/j.1523-1755.2005.00574.x
Schiffer, 2004, A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis, J Biol Chem, 279, 37004, 10.1074/jbc.M403534200
Fornoni, 2001, Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis, Am J Pathol, 158, 275, 10.1016/S0002-9440(10)63966-1
Wada, 2005, Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins, J Am Soc Nephrol, 16, 2615, 10.1681/ASN.2005020142
Kim, 1999, The cyclin kinase inhibitor p21Cip1/WAF1 limits visceral glomerular epithelial cell proliferation in experimental glomerulonephritis, Kidney Int, 55, 2349, 10.1046/j.1523-1755.1999.00504.x
Bijian, 2004, Extracellular matrix regulates glomerular epithelial cell survival and proliferation, Am J Physiol Renal Physiol, 286, F255, 10.1152/ajprenal.00259.2003
Ophascharoensuk, 1998, The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury, Nat Med, 4, 575, 10.1038/nm0598-575
Bridgewater, 2005, Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway, Kidney Int, 67, 1308, 10.1111/j.1523-1755.2005.00208.x
Durvasula, 2004, Activation of a local tissue angiotensin system in podocytes by mechanical strain, Kidney Int, 65, 30, 10.1111/j.1523-1755.2004.00362.x
Floege, 1996, Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephrology, J Clin Invest, 96, 2809, 10.1172/JCI118351
Foster, 2005, Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes, Am J Physiol Renal Physiol, 288, F48, 10.1152/ajprenal.00146.2004
Shankland, 1997, Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo, Kidney Int, 52, 404, 10.1038/ki.1997.347
Kuan, 1998, The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy, J Am Soc Nephrol, 9, 986, 10.1681/ASN.V96986
Sanwal, 2001, Puromycin aminonucleoside induces glomerular epithelial cell apoptosis, Expt Mol Path, 70, 54, 10.1006/exmp.2000.2345
Kriz, 1996, Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis, Nephrol Dial Transplant, 11, 1738, 10.1093/oxfordjournals.ndt.a027660
Griffin, 2003, Cell cycle control in glomerular disease, Springer Semin Immunopathol, 24, 441, 10.1007/s00281-003-0120-8
Shankland, 2000, Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis, Am J Physiol, 278, F515
Petermann, 2003, Mitotic cell cycle proteins increase in podocytes despite lack of proliferation, Kidney Int, 63, 113, 10.1046/j.1523-1755.2003.00723.x
Shankland, 1996, Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis, Kidney Int, 50, 1230, 10.1038/ki.1996.432
Moeller, 2004, Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis, J Am Soc Nephrol, 15, 61, 10.1097/01.ASN.0000102468.37809.C6
Griffin, 2005, Limitation of podocyte proliferation improves renal function in experimentation of crescentic glomerulonephritis, Kidney Int, 67, 977, 10.1111/j.1523-1755.2005.00161.x
Nelson, 2003, Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol, J Antimicrob Chemother, 51, 921, 10.1093/jac/dkg175
Milovanceva-Popovska, 2005, R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury, Kidney Int, 67, 1362, 10.1111/j.1523-1755.2005.00213.x
Petermann, 2003, Mitotic cell cycle proteins increase in podocytes despite lack of proliferation, Kidney Int, 63, 113, 10.1046/j.1523-1755.2003.00723.x
Shankland, 2000, Differential expression of CDK-inhibitors in human glomerular disease: role in podocyte proliferation and maturation, Kidney Int, 58, 674, 10.1046/j.1523-1755.2000.00213.x
Hiromura, 2001, Podocyte expression of the CDK-inhibitor p57 during development and disease, Kidney Int, 60, 2235, 10.1046/j.1523-1755.2001.00057.x
Barisoni, 1999, The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy, J Am Soc Nephrol, 10, 51, 10.1681/ASN.V10151
He, 2004, Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1, 2 pathways, J Clin Invest, 114, 643, 10.1172/JCI200421004
Couser, 2001, Complement (C5b-9) induces rat mesangial cell proliferation in vitro
Shankland, 1999, Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro, Kidney Int, 56, 538, 10.1046/j.1523-1755.1999.00560.x
Couser, 2001, Complement (C5b-9) induces DNA synthesis in rat mesangial cells, Kidney Int, 59, 905, 10.1046/j.1523-1755.2001.059003905.x
Pippin, 2003, DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes, J Clin Invest, 111, 877, 10.1172/JCI200315645
Bhathena, 2003, Glomerular basement membrane length to podocyte ratio in human nephronopenia: implications for focal segmental glomerulosclerosis, Am J Kidney Dis, 41, 1179, 10.1016/S0272-6386(03)00349-4
Gross, 2004, Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes, Lab Invest, 84, 452, 10.1038/labinvest.3700052
Gross, 2004, ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes, Diabetologia, 47, 316, 10.1007/s00125-003-1309-z
Xu, 2005, Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli, Kidney Int, 67, 944, 10.1111/j.1523-1755.2005.00158.x
Hoshi, 2002, Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats, Lab Invest, 82, 25, 10.1038/labinvest.3780392
Petermann, 2005, Mechanical stretch induces podocyte hypertrophy in vitro, Kidney Int, 67, 157, 10.1111/j.1523-1755.2005.00066.x
Miner, 2005, Building the glomerulus: a matricentric view, J Am Soc Nephrol, 16, 857, 10.1681/ASN.2004121139
Greiber, 1998, NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate, Kidney Int, 53, 654, 10.1046/j.1523-1755.1998.00796.x
Vega-Warner, 2004, Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside, Kidney Int, 66, 1881, 10.1111/j.1523-1755.2004.00962.x
Binder, 1999, Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: a model of steroid-resistant nephrosis sensitive to radical scavenger therapy, Am J Pathol, 154, 1067, 10.1016/S0002-9440(10)65359-X
Ricardo, 1994, Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats, J Am Soc Nephrol, 4, 1974, 10.1681/ASN.V4121974
Neale, 1994, Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts of type IV collagen, J Clin Invest, 94, 1577, 10.1172/JCI117499
Gwinner, 1999, Role of xanthine oxidase in passive Heymann nephritis in rats, J Am Soc Nephrol, 10, 538, 10.1681/ASN.V103538
Kojima, 2000, Protection of alpha (3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat, Am J Kidney Dis, 35, 1175, 10.1016/S0272-6386(00)70056-4
Asanuma, 2002, Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes, Kidney Int, 62, 822, 10.1046/j.1523-1755.2002.00539.x
McMillan, 1996, Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy, J Clin Invest, 97, 1094, 10.1172/JCI118502
Gerke, 2005, NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin and is cleaved from podocytes by metalloproteinases, J Am Soc Nephrol, 16, 1693, 10.1681/ASN.2004060439
Eremina, 2003, Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases, J Clin Invest, 111, 707, 10.1172/JCI17423
Chen, 2005, Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy, Nephrol Dial Transplant, 20, 1320, 10.1093/ndt/gfh837
Blanco, 2005, ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis, Kidney Int, 93, S10, 10.1111/j.1523-1755.2005.09303.x
Hoffmann, 2004, Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats, J Am Soc Nephrol, 15, 1475, 10.1097/01.ASN.0000127988.42710.A7
Ransom, 2005, Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes, Kidney Int, 67, 1275, 10.1111/j.1523-1755.2005.00205.x
Oseto, 2003, Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis, Kidney Int, 64, 1241, 10.1046/j.1523-1755.2003.00219.x